Diagnosis and management of adrenal cortical carcinoma

被引:23
作者
Fulmer B.R. [1 ]
机构
[1] Geisinger Health System, Department of Urology, M.C.13-16, Danville, PA 17822
关键词
Adrenal Mass; Laparoscopic Adrenalectomy; Adrenocortical Carcinoma; Adrenal Lesion; Mitotane;
D O I
10.1007/s11934-007-0024-6
中图分类号
学科分类号
摘要
Adrenal cortical carcinoma is a relatively uncommon malignancy that represents a significant clinical challenge for the development of optimal treatment strategies. Historically, successful treatment has relied upon rapid identification of the lesion, accurate staging with diagnostic imaging, and complete surgical extirpation. Although the framework of a successful treatment paradigm still relies on these steps, advances in diagnostic imaging have led to increased accuracy in diagnosis, and advances in laparoscopic surgical technique have served to reduce morbidity for patients facing treatment. This review focuses on a discussion of advances in modalities for the diagnosis and treatment of adrenal cortical carcinoma amenable to curative therapy. Patients that present with metastatic or locally advanced disease generally are treated with mitotane-based chemotherapy with or without the addition of cytotoxic drugs. Contemporary results of this treatment approach are presented in this review as well as a discussion of further directions for the treatment of patients with advanced disease. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:77 / 82
页数:5
相关论文
共 46 条
[1]  
Allolio B., Hahner S., Weismann D., Et al., Management of adrenocortical carcinoma, Clin Endocrinol (Oxf), 60, pp. 273-287, (2004)
[2]  
Liou L.S., Kay R., Adrenocortical carcinoma in children. Review and recent innovations, Urol Clin North Am, 27, pp. 403-421, (2000)
[3]  
Bornstein S.R., Stratakis C.A., Chrousos G.P., Adrenocortical tumors: Recent advances in basic concepts and clinical management, Ann Intern Med, 130, pp. 759-771, (1999)
[4]  
Wajchenberg B.L., Albergaria Pereira M.A., Medonca B.B., Et al., Adrenocortical carcinoma: Clinical and laboratory observations, Cancer, 88, pp. 711-736, (2000)
[5]  
Lipsett M.B., Treatment of adrenal carcinoma, Mod Treat, 3, pp. 1377-1388, (1966)
[6]  
Sidhu S., Gicquel C., Bambach C.P., Et al., Clinical and molecular aspects of adrenocortical tumourigenesis, ANZ J Surg, 73, pp. 727-738, (2003)
[7]  
Weiss L.M., Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors, Am J Surg Pathol, 8, pp. 163-169, (1984)
[8]  
Wagner M., Walter P.R., Ghnassia J.P., Et al., Adrenocortical tumors. I. Prognostic evaluation of a series of 17 cases using the Weiss criteria], Ann Pathol, 13, pp. 306-311, (1993)
[9]  
Vassilopoulou-Sellin R., Schultz P.N., Adrenocortical carcinoma. Clinical outcome at the end of the 20th century, Cancer, 92, pp. 1113-1121, (2001)
[10]  
Fassnacht M., Kenn W., Allolio B., Adrenal tumors: How to establish malignancy?, J Endocrinol Invest, 27, pp. 387-399, (2004)